Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Feb 3, 2009

Researchers Link Gene Profile, Molecular Pathways, and Transcription Factors to Survival in Ovarian Cancer

  • Scientists at the University of Groningen in the Netherlands have identified various molecular pathways and transcription factors that are associated with overall survival in advanced-stage ovarian cancer.

    The team was able to create an 86-gene ovarian cancer expression profile that discriminated between patients with unfavorable and favorable prognosis. The researchers were then able to confirm that 57 of the 86 genes were also correlated with survival in a second, entirely separate dataset.

    Additionally, the investigators found that 17 out of 167 pathways and 13 out of 111 transcription factors were associated with overall survival, of which 16 and 12, respectively, were confirmed in the independent dataset.

    For example, yhe team found that high expression of a gene encoding an FK506 binding protein—FKBP7—is associated with poor prognosis. This protein can be targeted with existing mTOR inhibitors. The authors acknowledge it is now important to carry out prospective studies to show that the signature performs effectively in a clinical setting.

    The researchers initially profiled a series of tissue samples obtained during surgery to remove cancerous tissue from 157 consecutive patients in duplicate using almost 35,000 70-mer oligonucleotide microarrays.

    The study is published this week in PLoS Medicine.

    ---

     



Related content

Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »